Cleared Traditional

SCHNEIDER MONORAIL 421 PERCU TRANS ANGIO (PTA) BAL (K921943) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K921943 · Schneider Intl., Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1992
Decision
54d
Days
Class 2
Risk

K921943 is an FDA 510(k) clearance for the SCHNEIDER MONORAIL 421 PERCU TRANS ANGIO (PTA) BAL. Classified as Catheter, Angioplasty, Peripheral, Transluminal (product code LIT), Class II - Special Controls.

Submitted by Schneider Intl., Ltd. (Plymouth, US). The FDA issued a Cleared decision on June 17, 1992 after a review of 54 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Schneider Intl., Ltd. devices

Submission Details

510(k) Number K921943 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 24, 1992
Decision Date June 17, 1992
Days to Decision 54 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
71d faster than avg
Panel avg: 125d · This submission: 54d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LIT Catheter, Angioplasty, Peripheral, Transluminal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - LIT Catheter, Angioplasty, Peripheral, Transluminal

All 152
Devices cleared under the same product code (LIT) and FDA review panel - the closest regulatory comparables to K921943.
BALLOON DILATATION CATHETER
K922610 · Boston Scientific Corp · Nov 1992
SHORT TEGWIRE -- MODIFIED
K924276 · Boston Scientific Corp · Nov 1992
SUB-4 SMALL VESSEL BALLOON DILATATION CATHETER
K924047 · Boston Scientific Corp · Nov 1992
ULTRA-THIN
K920547 · Boston Scientific Corp · May 1992
TEGWIRE (TM)
K913391 · Boston Scientific Corp · Nov 1991
SUB-4(TM), PERIPHERAL DILATATION CATHETER
K913689 · Boston Scientific Corp · Oct 1991